Skip to main content
. 2012 Apr 12;14(9):779–786. doi: 10.1038/gim.2012.39

Table 3. Mainz Severity Scores at baseline and 12 months after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal) in 11 patients with Fabry disease.

graphic file with name gim201239t3.jpg